| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |